PORTAGE BIOTECH INC
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About PRTG
Portage Biotech Inc. is a clinical-stage immuno-oncology company. The Company is engaged in advancing therapies to improve long-term treatment, response, and quality of life in patients with cancers. The Company’s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through the translational pipeline. Its adenosine antagonist platform include PORT-9 and PORT-8. PORT-9 and PORT-8 are in the preclinical stage. Its PORT-8 is a dual inhibitor of adenosine receptors 2A and 2B (A2A/A2B) to address solid tumors. Its PORT-9 is an A2B antagonist designed to treat colorectal and gastrointestinal cancers. Its iNKT Engager platform includes PORT- 3, which is in Phase I.
Find out what a historical investment in PORTAGE BIOTECH INC would be worth today using our PRTG stock calculator.
$15.25M
-
0.00%
151
$9.86
$8.88
$0.00
$23.01
$2.10
Ready to start your investing journey with Stake?
Open an accountPRTG FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PRTG
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PRTG
on Stake
Buy PRTG from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of PRTG from only US$10 with fractional shares
